Parliamentary Committee Recommendation Affects Healthcare Spending in Canada
A recent recommendation by the parliamentary committee to not expand Medical Assistance in Dying (MAID) to individuals with mental illness may have significant implications for Canada's healthcare spending.
According to a report by the Canadian Institute for Health Information (CIHI), in 2020, a total of 10.7 billion Canadian dollars were spent on mental health and addiction services in Canada. A significant portion of this expenditure is likely to remain unchanged if the MAID expansion is not implemented.
The potential impact on the pharmaceutical industry, particularly companies specializing in psychiatric medications, could be substantial. If individuals with mental illness continue to rely on traditional treatments, companies such as Valeant Pharmaceuticals International and Purdue Pharma Canada may experience increased demand for their products.
On the other hand, the expansion of MAID could have led to increased demand for palliative care services, potentially benefiting companies such as Hospice Association of Canada and Canadian Hospice Palliative Care Association. However, without the expansion, these companies may not see the same level of growth.
The recommendation also has implications for the healthcare workforce in Canada. A report by the Canadian Medical Association (CMA) found that the country faces a shortage of over 5,000 physicians, including psychiatrists. This shortage could be exacerbated if the demand for mental health services does not increase due to the MAID expansion.
While the recommendation is not a final decision, it is likely to influence the direction of healthcare spending in Canada. The impact on the economy and businesses in the healthcare industry will depend on how the government responds to the recommendation
